[HTML][HTML] Machine learning explainability in nasopharyngeal cancer survival using LIME and SHAP

RO Alabi, M Elmusrati, I Leivo, A Almangush… - Scientific Reports, 2023 - nature.com
Nasopharyngeal cancer (NPC) has a unique histopathology compared with other head and
neck cancers. Individual NPC patients may attain different outcomes. This study aims to …

[HTML][HTML] Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma

XJ Du, GY Wang, XD Zhu, YQ Han, F Lei, LF Shen… - Cancer Cell, 2024 - cell.com
Summary The AJCC/UICC TNM classification describes anatomic extent of tumor
progression and guides treatment decisions. Our comprehensive analysis of 8,834 newly …

[HTML][HTML] Prognostic biomarkers for survival in nasopharyngeal carcinoma: a systematic review of the literature

KA Islam, LKY Chow, NW Kam, Y Wang, CL Chiang… - Cancers, 2022 - mdpi.com
Simple Summary Nasopharyngeal carcinoma (NPC) is an important Epstein–Barr virus
(EBV)-associated malignancy. Currently, tumor–nodes–metastases (TNM) staging and …

[HTML][HTML] Precision Medicine for Nasopharyngeal Cancer—A Review of Current Prognostic Strategies

L Suryani, HPY Lee, WK Teo, ZK Chin, KS Loh, JK Tay - Cancers, 2024 - mdpi.com
Simple Summary The current standard of care for nasopharyngeal carcinoma (NPC) is
predominantly guided by the American Joint Committee on Cancer (AJCC)/Union for …

[HTML][HTML] Real-time in vivo cancer staging of nasopharyngeal carcinoma patients with rapid fiberoptic Raman endoscopy

C Shu, W Zheng, K Lin, CM Lim, Z Huang - Talanta, 2023 - Elsevier
Cancer staging is important to guide treatment and for prognostication. This work aims to
demonstrate the ability of rapid fiberoptic Raman endoscopy for real-time in vivo cancer …

[HTML][HTML] Nomograms based on the lymphocyte–albumin–neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive …

S Zhang, Z Chen, J Ling, Y Feng, Y Xie, X Liu, C Hu… - Scientific Reports, 2024 - nature.com
Much evidence has accumulated to show that inflammation and nutritional status are
associated with the prognosis of patients with various cancers. The present study was …

[HTML][HTML] A promising predictive biomarker combined EBV NDA with PNI for nasopharyngeal carcinoma in nonendemic area of China

Q He, Y Huang, L Yuan, Z Wang, Q Wang, D Liu, L Li… - Scientific Reports, 2023 - nature.com
In endemic areas, EBV DNA is used to guide diagnosis, detect recurrence and distant
metastasis of NPC. Until now, the importance of EBV DNA in the prediction of NPC has …

[HTML][HTML] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal …

Z Yang, Q Zuo, R Liu, H Wu, L Xiong, J Jia, Z Xiang - BMC cancer, 2023 - Springer
Purpose We aimed to investigate the efficacy and side effects of concurrent
chemoradiotherapy, with or without nimotuzumab, for the treatment of locally advanced …

[HTML][HTML] Quantitative spatial characterization of lymph node tumor for N stage improvement of nasopharyngeal carcinoma patients

J Zhang, X Teng, S Lam, J Sun, ALY Cheung, SCY Ng… - Cancers, 2022 - mdpi.com
Simple Summary The N staging system for Nasopharyngeal Carcinoma (NPC) is constantly
improving for better survival risk stratification with accumulating clinical evidence …

[HTML][HTML] Development of A Nomogram for Progression-free Survival in Patients with Stage II/T3N0 Nasopharyngeal Carcinoma to Explore Different Treatment …

C Yan, R Zhao, KH Chen, BY Chen, CJ Zhang… - Journal of …, 2023 - ncbi.nlm.nih.gov
Purpose To explore the prognostic value of clinical and serological risk factors for
progression-free survival (PFS) in stage II and T3N0 nasopharyngeal carcinoma (NPC) and …